Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver in Milan
Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology Annual Meeting
Aventis Energy Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project and Concludes Inaugural Drill Program
Standard Uranium Intersects Anomalous Radioactivity in Multiple Drill Holes at the Corvo Uranium Project; Concludes Inaugural Drill Program
